Acumen Research and Consulting Virus Filtration Market Size to witness a CAGR of | Page 3

manufacturers in the region. Advancement in filtration technology, increasing acceptance of biopharmaceuticals, coupled with rise in R&D expenses by key players supports the growth of virus filtration market in Europe. View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/virus-filtration- market Asia Pacific is anticipated to be the most attractive market for virus filtration market during the forecast period owing to the rising awareness regarding the spread of chronic diseases such as diabetes, cancer, and malaria caused by virus infection. In addition, the region is anticipated to be a lucrative revenue pocket owing to the favorable government initiatives and cheap labor cost. Pharmaceutical & Biotechnology Companies led the virus filtration market Based on end-user, the global virus filtration market has been segmented into pharmaceutical & biotechnology companies, medical devices companies, research institutes and contract research organizations. The pharmaceutical & biotechnology companies accounted for the maximum share of virus filtration market in 2013 owing to the large number of pharmaceutical & biotechnology globally. Some of the key players profiled in the report include Lonza, Danaher, WuXi PharmaTech (Cayman) Inc., Merck KGaA, General Electric, Charles River Laboratories International, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, and Asahi Kasei Medical Co., Ltd. Most of the key players have adopted the strategy such as merger & acquisition, new product launch, and expansion in order to have a strong foothold in the market. Would like to place an order or any question, please feel free to contact at [email protected] | [phone]